| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/19/2010 | EP2185539A1 Viral polymerase inhibitors |
| 05/19/2010 | EP2185538A2 Tetrahydropyridine carboxamide derivatives as trpvl antagonists |
| 05/19/2010 | EP2185537A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions |
| 05/19/2010 | EP2185535A1 Sulfamide derivative useful for the treatment of epilepsy |
| 05/19/2010 | EP2185530A1 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 05/19/2010 | EP2185529A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/19/2010 | EP2185528A1 Process for the preparation of methyl ester of rosuvastatin |
| 05/19/2010 | EP2185527A2 Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium |
| 05/19/2010 | EP2185526A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives |
| 05/19/2010 | EP2185524A1 Novel peptide inhibitors of hepatitis c virus replication |
| 05/19/2010 | EP2185523A2 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 05/19/2010 | EP2185521A2 Compounds and methods for modulating rho gtpases |
| 05/19/2010 | EP2185517A1 Process for preparing a leukotriene antagonist and an intermediate thereof |
| 05/19/2010 | EP2185516A2 Polymorphs of 3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid sodium salt or a hydrate thereof and methods for making the same |
| 05/19/2010 | EP2185515A2 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 05/19/2010 | EP2185514A1 Vinyl-aryl derivatives for inflammation and immune-related uses |
| 05/19/2010 | EP2185512A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 05/19/2010 | EP2185511A2 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 05/19/2010 | EP2185510A2 New salts of bazedoxifene |
| 05/19/2010 | EP2185505A2 Acyl-urea derivatives and uses thereof |
| 05/19/2010 | EP2185504A2 Bis-aromatic compounds useful in the treatment of inflammation |
| 05/19/2010 | EP2185503A1 Monoamide derivatives as orexin receptor antagonists |
| 05/19/2010 | EP2185502A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands |
| 05/19/2010 | EP2185501A1 Salts of tramadol and naproxen and their crystal forms in the treatment of pain |
| 05/19/2010 | EP2185174A1 Use of trim72 as a target for muscle and heart enhancer |
| 05/19/2010 | EP2185173A1 Use of phosphatases to treat neuroblastomas and medullogastomas |
| 05/19/2010 | EP2185160A2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders |
| 05/19/2010 | EP2185159A2 Bortezomib and process for producing same |
| 05/19/2010 | EP2185158A1 Use of phosphatidylcholine for treating steroid-dependent and steroid-refractory ulcerative colitis |
| 05/19/2010 | EP2185157A1 Dhea compositions for treating menopause |
| 05/19/2010 | EP2185156A1 Treatments and prevention of hydrocephalus |
| 05/19/2010 | EP2185155A1 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands |
| 05/19/2010 | EP2185151A1 Anti-inflammatory composition |
| 05/19/2010 | EP2185149A1 Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
| 05/19/2010 | EP2185148A2 Use of travoprost for treating hair loss |
| 05/19/2010 | EP2185147A1 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof |
| 05/19/2010 | EP2185146A1 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid |
| 05/19/2010 | EP2185145A1 Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection |
| 05/19/2010 | EP2185144A2 Composition for prevention or treatment of bone metabolism disorder comprising d-pinitol as an active ingredient |
| 05/19/2010 | EP2185143A2 Antimicrobial parenteral formulation |
| 05/19/2010 | EP2185139A2 Bupropion hydrobromide and therapeutic applications |
| 05/19/2010 | EP2185131A2 Continuous process for microspheres production by using expanded fluids |
| 05/19/2010 | EP2185130A2 Tablet containing donepezile hydrochloride in amorphous form |
| 05/19/2010 | EP2185008A2 Reduction of oxidative stress damage during or after exercise |
| 05/19/2010 | EP2184994A1 Heterocycle-aryl compounds for inflammation and immune-related uses |
| 05/19/2010 | EP2184990A2 3' substituted compounds having 5-ht6 receptor affinity |
| 05/19/2010 | EP2184988A1 Small molecule inhibitors of lck sh2 domain binding |
| 05/19/2010 | EP2184987A1 Bi-dentate compounds as kinase inhibitors |
| 05/19/2010 | EP2184986A2 Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
| 05/19/2010 | EP2184984A1 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| 05/19/2010 | EP2184981A1 Pyridine carboxamide orexin receptor antagonists |
| 05/19/2010 | EP2094116B1 Solid or aqueous alkaline preparation comprising a creatine component, process for the production thereof and the use thereof |
| 05/19/2010 | EP1996176B1 Compositions to reduce blood glucose levels and treat diabetes |
| 05/19/2010 | EP1988786B1 Oligosaccharide mixture |
| 05/19/2010 | EP1899335B1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors |
| 05/19/2010 | EP1896485B1 Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors |
| 05/19/2010 | EP1856059B1 Multimers of pyrimidinone derivatives and their use as human neutrophil elastase inhibitors |
| 05/19/2010 | EP1720871B1 3,5-disubstituted 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors |
| 05/19/2010 | EP1718337B1 New combinations of a 5-ht3 receptor antagonist with racecadotril or dexecadotril |
| 05/19/2010 | EP1706390B1 Isoxazole derivatives and their use as cyclooxygenase inhibitors |
| 05/19/2010 | EP1706372B1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 05/19/2010 | EP1653815B1 Methods for reducing astringency |
| 05/19/2010 | EP1606246B1 Method for producing 2-cyan-3-hydroxy-n-(phenyl)but-2-ene amides |
| 05/19/2010 | EP1599467B1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 05/19/2010 | EP1575575B1 Safe chemical uncouplers for the treatment of obesity |
| 05/19/2010 | EP1558246B1 Proline derivatives having affinity for the calcium channel alpha-2-delta subunit |
| 05/19/2010 | EP1521749B1 PHENYL-(4-(3-PHENYL-1H-PYRAZOL-4-YL)-PYRIMIDIN-2-Yl)-AMINE DERIVATIVES |
| 05/19/2010 | EP1485380B1 Azolylaminoazines as inhibitors of protein kinases |
| 05/19/2010 | EP1467995B1 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 05/19/2010 | EP1463487B1 Liposomal delivery of vitamin e based compounds |
| 05/19/2010 | EP1461055B1 Anti-bacterial extracts from mammea americana |
| 05/19/2010 | EP1438063B1 Glutation precursors for the treatment of neuropsychiatric disorders |
| 05/19/2010 | EP1435994B1 Novel use of pulmonary surfactant |
| 05/19/2010 | EP1392242B1 Method of forming an aerosol for inhalation delivery |
| 05/19/2010 | EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same |
| 05/19/2010 | EP1368060B1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 05/19/2010 | EP1343510B1 Light stabilized antimicrobial materials |
| 05/19/2010 | EP1214097B9 Nucleic acids encoding polyepitope polypeptides |
| 05/19/2010 | EP1180991B1 Gambogic acid derivatives as activators of caspases and inducers of apoptosis |
| 05/19/2010 | EP0907735B9 Modulators of tissue regeneration |
| 05/19/2010 | EP0888374B1 HIGH AFFINITY NUCLEIC ACID LIGANDS OF THE COMPLEMENT SYSTEM PROTEIN C1q |
| 05/19/2010 | CN1994341B Preparation process of total phenolic acids of water cress and pharmaceutical formulation using the ingredient as bulk drug and use thereof for treating liver disease |
| 05/19/2010 | CN1985916B Anaer vagina cleaning effervescent tablet and its production process |
| 05/19/2010 | CN1981779B Xanthosine composition and its production method |
| 05/19/2010 | CN1981586B Method for purifying condensate of tea extraction compound |
| 05/19/2010 | CN1977886B Medicinal composition of oxymatrine, ganoderma lucidum and astragalus |
| 05/19/2010 | CN1977885B Antihepatitis medicinal composition |
| 05/19/2010 | CN1973877B Calamus effective-part extract and its use |
| 05/19/2010 | CN1957920B Anti cancer slow release agent carrying fluorouracil and synergist |
| 05/19/2010 | CN1943332B Method for producing super fine silk yarn |
| 05/19/2010 | CN1935147B New use of radix sanguisorbae total saponin extract |
| 05/19/2010 | CN1927185B Maleic acid trimebutine slow release tablet comprising quick release part and preparing method thereof |
| 05/19/2010 | CN1927175B Compound recipe anticancer slow release injection comprising tetrazole violet |
| 05/19/2010 | CN1923825B Novel antibiotic Chemomycin A and preparation method thereof |
| 05/19/2010 | CN1923173B Anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof |
| 05/19/2010 | CN1923171B Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof |
| 05/19/2010 | CN1919174B Anticancer slow release agent including nimustine and its synergist |
| 05/19/2010 | CN1875936B Anticancer sustained release agent containing clorfarabine and cytotoxic drug |
| 05/19/2010 | CN101711284A Use of anti-egfr antibodies in treatment of egfr mutant mediated disease |
| 05/19/2010 | CN101711254A Synthetic bile acid composition, method, and preparation |